CareDx CMO Sales Trigger: RWE & Medical Affairs Pitch

New CMO at CareDx unlocks a real-world evidence sales trigger. Pitch our RWE platform and medical affairs automation. Fuel your pipeline and hit your commission.

Published on


Do not index
Do not index

🚀 Battle Card: CareDx, Inc.

Quick trigger: Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer (Oct 1, 2025)
 
👤 Decision Maker in the News
 
💡 Why It Matters
  • A globally recognized transplant expert is now steering medical affairs → Source
 
🎯 Core Pain Point
  • Scaling clinician engagement for new precision-medicine solutions
  • Proving clinical differentiation with robust real-world evidence
 
💰 What to Pitch
  • Primary: Real-World Evidence Platform → Accelerate clinical validation & market adoption
  • Expansion: Medical Affairs Automation Suite → Streamline MSL workflows & data insights
 
🗺️ Quick Context
  • HQ: Brisbane, CA
  • Employees: ≈ 500
  • Rev: ≈ $200 M
 

🤼 Competitive Intel

Which other vendors you’ll probably face to win CareDx’s business.
 
  • Veeva SystemsMedical Affairs
    • Unique edge: Best-in-class MSL engagement tools
    • Evaluated by Head of Medical Affairs for user adoption
  • Medidata (Dassault Systèmes)Clinical Data Mgmt
    • Unique edge: Integrated trial & RWE data hub
    • Evaluated by EVP Clinical Development for trial efficiency
  • IQVIAReal-World Evidence
    • Unique edge: Massive patient & claims datasets
    • Evaluated by Dir. RWE for depth of analytics
  • Oracle Health SciencesClinical & RWE
    • Unique edge: Scalable cloud platform
    • Evaluated by CIO for IT alignment
  • ClarivateRWE & Analytics
    • Unique edge: AI-powered insights on publications & trials
    • Evaluated by VP Medical Affairs for intelligence breadth
 

✅ Do-Now Checklist

Connect with Jeffrey John Teuteberg, MD on LinkedIn (link above)
Draft first-touch email + DM using the Copy-My-Prompt block below
Schedule follow-ups in your CRM (Day 3 & Day 10)
 

Copy-My-Prompt (Step 7)

“Hi Dr. Teuteberg, congrats on joining CareDx! With your transplant expertise guiding medical affairs, I’d love to share how our Real-World Evidence Platform can accelerate CareDx’s clinical validation roadmap. Have 15 mins next week?”
 

Next Step

Leverage this CareDx sales trigger to book meetings today. For more high-octane intel on the next CareDx sales trigger—and every big-name sales cue—**Subscribe to NewsletterForLeads**
 

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑❑
OFFER_BRIEF   = ❑Real-World Evidence Platform❑
PROOF_METRIC  = ❑≈ TBD❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑punchy❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Jeffrey
COMPANY     = CareDx, Inc.
DEPT        = Medical Affairs
SIZE        = ≈ 15
BOTTLENECK  = Scaling clinician engagement for new precision-medicine solutions
EVENT       = Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
DETAIL      = Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
PAIN        = Scaling clinician engagement for new precision medicine
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20251027720132&div=41152219
SIM_CO      = ≈ TBD
WIN_METRIC  = ≈ TBD
NEXT_SIZE   = ≈ 50
EMP_EST     = ≈ 500
REV_EST     = ≈ $200M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈ 15-person Medical Affairs

Jeffrey—noticed your Medical Affairs team is ≈ 15.

That’s when Scaling clinician engagement for new precision-medicine solutions slows growth.

We helped ≈ TBD fix this with Real-World Evidence Platform.

Result: ≈ TBD.  
Quick call?

PS—next bottleneck hits ≈ 50.

DM ≤45 words, TONE:
Saw your post about Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer — Scaling clinician engagement for new precision medicine.  
Real-World Evidence Platform. ≈ TBD. Quick chat?

Join other 3200+ marketers now!

Ready to take the next big step for your business?

Subscribe